Cargando…

Health-related quality of life of multiple sclerosis patients: a European multi-country study

BACKGROUND: Inconsistent use of generic and disease-specific health-related quality of life (HRQOL) instruments in multiple sclerosis (MS) studies limits cross-country comparability. The objectives: 1) investigate real-world HRQOL of MS patients using both generic and disease-specific HRQOL instrume...

Descripción completa

Detalles Bibliográficos
Autores principales:	Visser, Laurenske A., Louapre, Celine, Uyl-de Groot, Carin A., Redekop, William K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980344/ https://www.ncbi.nlm.nih.gov/pubmed/33743785 http://dx.doi.org/10.1186/s13690-021-00561-z

Ejemplares similares

The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis
por: Visser, Laurenske A., et al.
Publicado: (2021)

Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment
por: Zaim, Remziye, et al.
Publicado: (2023)

Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer
por: Zaim, Remziye, et al.
Publicado: (2022)

Economic evaluations of big data analytics for clinical decision-making: a scoping review
por: Bakker, Lytske, et al.
Publicado: (2020)

Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
por: Ansaripour, Amir, et al.
Publicado: (2017)

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer
por: Zaim, Remziye, et al.
Publicado: (2023)

How can we discover the most valuable types of big data and artificial intelligence-based solutions? A methodology for the efficient development of the underlying analytics that improve care
por: Bakker, Lytske, et al.
Publicado: (2021)

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
por: de Groot, S., et al.
Publicado: (2017)

Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran
por: Ansaripour, Amir, et al.
Publicado: (2018)

Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma
por: Bakker, LJ, et al.
Publicado: (2023)

Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient Perspectives
por: Visser, L A, et al.
Publicado: (2021)

Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe
por: Uyl-de Groot, Carin A., et al.
Publicado: (2020)

Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices
por: Dane, Aniek, et al.
Publicado: (2023)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
por: van der Gronde, Toon, et al.
Publicado: (2017)

Multinomial network meta-analysis using response rates: relapsed/refractory multiple myeloma treatment rankings differ depending on the choice of outcome
por: van Beurden-Tan, Chrissy H. Y., et al.
Publicado: (2022)

Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020)

Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: A pharmaco‐economic assessment
por: Uyl‐de Groot, Carin A., et al.
Publicado: (2020)

Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach
por: Clarijs, Marloes E., et al.
Publicado: (2021)

The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T(2)* mapping at 7 T MRI
por: Louapre, Céline, et al.
Publicado: (2016)

Assessing the impact of caregiving on informal caregivers of adults with a mental disorder in OECD countries: A systematic literature review of concepts and their respective questionnaires
por: Bremmers, Leonarda G. M., et al.
Publicado: (2022)

Voice-Related Quality of Life in Patients with Multiple Sclerosis
por: Hamdan, Abdul Latif, et al.
Publicado: (2012)

Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype
por: Brochet, Bruno, et al.
Publicado: (2022)

Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study
por: Ndosi, Mwidimi, et al.
Publicado: (2018)

Imaging Characteristics of Choroid Plexuses in Presymptomatic Multiple Sclerosis: A Retrospective Study
por: Ricigliano, Vito A.G., et al.
Publicado: (2022)

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
por: De Groot, S., et al.
Publicado: (2017)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Expanded Access as a source of real‐world data: An overview of FDA and EMA approvals
por: Polak, Tobias B., et al.
Publicado: (2020)

Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
por: Xander, Nicolas S. H., et al.
Publicado: (2023)

Diabetes-related quality of life in six European countries measured with the DOQ-30
por: Pilv, Liina, et al.
Publicado: (2021)

Management of multiple sclerosis patients in central European countries: current needs and potential solutions
por: Berger, Thomas, et al.
Publicado: (2018)

Contributing factors to health‐related quality of life in multiple sclerosis
por: Biernacki, Tamás, et al.
Publicado: (2019)

Health-related Quality of Life of People with Multiple Sclerosis in Oman
por: Natarajan, Jansirani, et al.
Publicado: (2021)

Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
por: Salhofer-Polanyi, S., et al.
Publicado: (2018)

Fampridine and quality of life in individuals with multiple sclerosis
por: Sagawa, Yoshimasa, et al.
Publicado: (2016)

Contributing Factors to the Quality of Life in Multiple Sclerosis
por: Sehanovic, Aida, et al.
Publicado: (2020)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
por: O’Mahony, Julia, et al.
Publicado: (2022)

Onderdiagnostiek bij kanker door de COVID-19-crisis naar diagnose, leeftijd en provincie: Een cruciale rol voor eerstelijnszorgverleners
por: Uyl-de Groot, Carin A., et al.
Publicado: (2020)

Quality of life among multiple sclerosis patients in Saudi Arabia
por: Algahtani, Hussein A., et al.
Publicado: (2017)

The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review
por: Cacciatore, Pasquale, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62aadnjme0gephravn4h02anjr